AAV-BASED GENE THERAPY APPROACH FOR THE TREATMENT OF LGMD2B / DYSFERLINOPATHY
CR20260050APending Publication Date: 2026-06-09KATE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CR202600050
- Authority / Receiving Office
- CR · CR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-07-10
- Filing Date
- 2024-07-10
- Publication Date
- 2026-06-09
Abstract
The present invention relates to compositions and methods for the treatment of dysferlinopathies.
Need to check novelty before this filing date? Find Prior Art